Tag Archives: 2012 BIO International Convention

By Don Joseph, CEO, BIO Ventures for Global Health In March, we at BIO Ventures for Global Health (BVGH) released a report, Developing New Drugs and Vaccines for Neglected Diseases of the Poor: The Product Developer Landscape, which showed that small- to medium-sized biotechnology companies are participating in a high percentage (41 percent) of projects targeting neglected diseases of the developing world. The findings of this report were surprising, given the financial risks these companies Read More >

By Bob Coughlin, President & CEO, MassBio You will surely be very busy during your time at the 2012 BIO International Convention but you might find you have a little downtime to explore Boston. If you’re looking for suggestions, here are some of my favorite places to see, things to do, and restaurants to enjoy in the city. First of all, let me mention the Red Sox are home… Fenway Park, the oldest Major League Baseball Read More >

The BIO International Convention is the largest global event for the biotechnology industry; it attracts the biggest names in biotech and offers key networking and partnering opportunities. The event is also a great opportunity to connect with the online biotech community and we’re ramping up our social media efforts for the 2012 BIO International Convention, beginning on Monday, June 18 in Boston. If you’d like to join the online conversation, here are some tips, tricks, Read More >

By Tejal U. Naik, Participant, International BioGENEius Challenge BioGENEius is the premier competition for high school students that recognizes outstanding research in biotechnology. For me, this was the first time I was truly submersed into a real scientific field. This is ironic considering I was born to parents who are research scientists in the cardiovascular field. I was always surrounded by science and research, but it was not until I participated in the BioGENEius competition Read More >

BIO is glad to hear that the American Society for Biochemistry and Molecular Biology (ASBMB) is helping the biotech community by promoting diversity. ASBMB has put forth a number of recommendations in response to an alarming 2011 NIH study showing that black researchers were 10% less likely to receive funding than white researchers. These suggestions all aim to ease access to resources and educate minority scientists on how to succeed in the research community- read Read More >